Hepion pharmaceuticals issues letter to shareholders urging support for proposed merger with pharma two b

Transaction creates opportunity to share in potential upside of pharma two b's late-clinical stage candidate to treat parkinson's disease

HEPA Ratings Summary

HEPA Quant Ranking